Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. Lax-A-Day: new PEG oral laxativePendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. CFP announces new president Peter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. LETTERS: B.C. college defends real-world walk-in policy PENSIONS: My German pension Eggs may be good for blood pressure after all Cooking process breaks proteins into ACE inhibitory peptides DIGESTIVE DISEASES: Ontario colorectal screening program seeing successes Cancer and high-risk adenoma detection rate with two or more positive FOBTs better than screening due to family history PENSIONS: Canadian pension rules outdated ORTHOPEDICS: That shoe may not fit First Previous 3871 3872 3873 3874 3875 Next Last
